Ageing
Conditions
Interventions
Group 1: Athletes participating in the 2012 European Veteran Athletic Championships. Depending on subject profile and consent, several tests were performed in the study.
Group 2: The Muscle Biopsy con
Sponsors
Deutsches Zentrum für Luft- und Raumfahrt
Institut für Luft- und Raumfahrtmedizin
Weltraumphysiologie
Eligibility
Sex/Gender
All
Age
35 Years to 110 Years
Inclusion criteria
Inclusion criteria: There are individual criteria for each test: 1. Jump and hopping tests: Any master athlete 2. Heat exchange, oxygen delivery and consumption limitations of muscle function: Any Master Athlete. 3. Blood samples for determination of oxidative stress, systemic inflammation, lipoprotein profile, glucose, insulin: Any Master Athlete 4. Muscle Biopsy (Biopsy): Any master athlete 5. Follow-up of bone density measurements (pQCT): Athletes who have already participated in our pQCT-study in the past 6. Sarcopenia: Any master athlete 7. Resting metabolic rate: Any master athlete 8. Incidence of injuries and medical emergencies in master athletes during competition: Any master athlete with an injury during the competition 9. Muscle Biopsy Control group (DLR Cologne): No regular training for a specific sport on a competition level. As this is a control group, participants will be matched with the athletes.
Exclusion criteria
Exclusion criteria: There are individual criteria for each test: 1. Jump and hopping tests: none 2. Heat exchange, oxygen delivery and consumption limitations of muscle function: Neuromuscular disorders Cardiovascular history including: o previous myocardial infarction o previous stroke o known cardiac valve insufficiencies o arrhythmias major surgery in the last two years organ transplants 3. Blood samples for determination of oxidative stress, systemic inflammation, lipoprotein profile, glucose, insulin: Increased bleeding tendency (hemophilia, regular use of anticoagulants) 4. Muscle Biopsy (Biopsy): Increased bleeding tendency (hemophilia, regular use of anticoagulants), history of intolerance to local anesthetics, neuromuscular disorders, cardiovascular history including: o previous myocardial infarction o previous stroke o known cardiac valve insufficiencies o arrhythmias major surgery in the last two years organ transplants 5. Follow-up of bone density measurements (pQCT): Athletes who have not participated in our study in the past, pregnant athletes 6. Sarcopenia: Athletes with a cardiac pacemaker or an implantable cardioverter defibrillator 7. Resting metabolic rate: none 8. On location: Incidence of injuries and medical emergencies in master athletes during competition: none 9. Muscle Biopsy Control group (DLR Cologne): As this is a control group, participants will be matched with the athletes. Otherwise same exclusion criteria as in test station 3.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Muscle force measured once with jump- and hopping tests, Vo2max measured once by spiroergometry, determination of muscle mass once with bioimpedance, basal metabolic rate measured once by a fasting-measurement, assessment of injuries and emergencies by data collecion with cards. | — |
Countries
Germany
Contacts
Public ContactJörn Rittweger
Deutsches Zentrum für Luft- und Raumfahrt Institut für Luft- und Raumfahrtmedizin Weltraumphysiologie
Outcome results
None listed